Enhancement of the function of rat serotonin and norepinephrine neurons by sustained vagus nerve stimulation

Journal of Psychiatry and Neuroscience

Volumn 34, Issue 4, 2009, Pages 272-280

  Manta, Stella ^a   Dong, Jianming ^b   Debonnel, Guy ^b   Blier, Pierre ^a,b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; NORADRENALIN; SEROTONIN; 2 BROMO N (2 CHLOROETHYL) N ETHYLBENZYLAMINE; ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BENZYLAMINE DERIVATIVE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PIPERAZINE DERIVATIVE; PRAZOSIN; PYRIDINE DERIVATIVE; SEROTONIN 1A RECEPTOR; SEROTONIN ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ELECTROPHYSIOLOGY; DORSAL RAPHE NUCLEUS; ELECTRODE; HIPPOCAMPUS; LOCUS CERULEUS; MALE; NERVE CELL; NONHUMAN; PYRAMIDAL NERVE CELL; RAT; VAGUS NERVE STIMULATION; ACTION POTENTIAL; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; METHODOLOGY; PATHOLOGY; PHYSIOLOGY; RAPHE NUCLEUS; SPRAGUE DAWLEY RAT;

ACTION POTENTIALS; ADRENERGIC AGENTS; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; BENZYLAMINES; HIPPOCAMPUS; LOCUS COERULEUS; NEURONS; NOREPINEPHRINE; PIPERAZINES; PRAZOSIN; PYRAMIDAL CELLS; PYRIDINES; RAPHE NUCLEI; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT1A; RECEPTORS, ADRENERGIC, ALPHA-1; SEROTONIN; SEROTONIN ANTAGONISTS; VAGUS NERVE STIMULATION;

EID: 70149083277     PISSN: 11804882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Foley JO, Dubois F. Quantitative studies of the vagus nerve in the cat. I: the ratio of sensory and motor studies. J Comp Neurol 1937;67:49-67.
2. Buoni S, Mariottini A, Pieri S, et al. Vagus nerve stimulation for drug-resistant epilepsy in children and young adults. Brain Dev 2004;26:158-163 (Pubitemid 38367898)
3. Elger G, Hoppe C, Falkai P, et al. Vagus nerve stimulation is associated with mood improvements in epilepsy patients. Epilepsy Res 2000;42:203-210 (Pubitemid 30829566)
4. Schachter SC. Vagus nerve stimulation: mood and cognitive effects. Epilepsy Behav 2004;5 Suppl 1:S56-9.
5. Sackeim HA, Rush AJ, George MS, et al. Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome. Neuropsychopharmacology 2001;25:713-728 (Pubitemid 32995954)
6. Marangell LB, Rush AJ, George MS, et al. Vagus nerve stimulation (VNS) for major depressive episodes: one year outcomes. Biol Psychiatry 2002;51:280-287
7. Nahas Z, Marangell LB, Husain MM, et al. Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. J Clin Psychiatry 2005;66:1097-1104 (Pubitemid 41442274)
8. Schlaepfer TE, Frick C, Zobel A, et al. Vagus nerve stimulation for depression: efficacy and safety in a European study. Psychol Med 2008;38:651-661
9. Krahl SE, Senanayake SS, Pekary AE, et al. Vagus nerve stimulation (VNS) is effective in a rat model of antidepressant action. J Psychiatr Res 2004;38:237-240
10. Daban C, Martinez-Aran A, Cruz N, et al. Safety and efficacy of vagus nerve stimulation in treatment-resistant depression. A systematic review. J Affect Disord 2008;110:1-15.
11. Chae JH, Nahas Z, Lomarev M, et al. A review of functional neuroimaging studies of vagus nerve stimulation (VNS). J Psychiatr Res 2003;37:443-455 (Pubitemid 37238938)
12. Pineyro G, Blier P. Autoregulation of serotonin neurons: role in antidepressant drug action. Pharmacol Rev 1999;51:533-591 (Pubitemid 29420214)
13. Blier P, de Montigny C. Current advances and trends in the treatment of depression. Trends Pharmacol Sci 1994;15:220-226 (Pubitemid 24210726)
14. Santarelli L, Saxe M, Gross C, et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 2003;301:805-809 (Pubitemid 36962615)
15. Haddjeri N, Blier P, de Montigny C. Long-term antidepressant treatments result in a tonic activation of forebrain 5-HT1A receptors. J Neurosci 1998;18:10150-10156 (Pubitemid 28543788)
16. Svensson TH, Bunney BS, Aghajanian GK. Inhibition of both noradrenergic and serotonergic neurons in brain by the alpha-adrenergic agonist clonidine. Brain Res 1975;92:291-306.
17. Curet O, de Montigny C. Electrophysiological characterization of adrenoceptors in the rat dorsal hippocampus. III. Evidence for the physiological role of terminal alpha 2-adrenergic autoreceptors. Brain Res 1989;499:18-26. (Pubitemid 19241608)
18. Schoffelmeer AN, Mulder AH. 3H-noradrenaline release from rat neocortical slices in the absence of extracellular Ca2+ and its presynaptic alpha 2-adrenergic modulation. A study on the possible role of cyclic AMP. Naunyn Schmiedebergs Arch Pharmacol 1983;323:188-192
19. Crews FT, Smith CB. Presynaptic alpha-receptor subsensitivity after long-term antidepressant treatment. Science 1978;202:322-324
20. McMillen BA, Warnack W, German DC, et al. Effects of chronic desipramine treatment on rat brain noradrenergic responses to alpha-adrenergic drugs. Eur J Pharmacol 1980;61:239-246 (Pubitemid 10135188)
21. Vandermaelen CP, Aghajanian GK. Electrophysiological and pharmacological characterization of serotonergic dorsal raphe neurons recorded extracellularly and intracellularly in rat brain slices. Brain Res 1983;289:109-119
22. Millan MJ, Rivet JM, Gobert A, et al. 5-HT1A receptors and the tailflick response. VI. Intrinsic alpha 1A-adrenoceptor antagonist properties can mask the actions of 5-HT1A receptor agonists in the spontaneous tail-flick paradigm. J Pharmacol Exp Ther 1994;269:121-131 (Pubitemid 24143243)
23. Dorr AE, Debonnel G. Effect of vagus nerve stimulation on serotonergic and noradrenergic transmission. J Pharmacol Exp Ther 2006;318:890-898 (Pubitemid 44061265)
24. Grzanna R, Berger U, Fritschy JM, et al. Acute action of DSP-4 on central norepinephrine axons: biochemical and immunohistochemical evidence for differential effects. J Histochem Cytochem 1989;37:1435-1442 (Pubitemid 19212762)
25. Logue MP, Growdon JH, Coviella IL, et al. Differential effects of DSP-4 administration on regional brain norepinephrine turnover in rats. Life Sci 1985;37:403-409
26. Aghajanian GK, Vandermaelen CP. Intracellular identification of central noradrenergic and serotonergic neurons by a new double labeling procedure. J Neurosci 1982;2:1786-1792
27. Grace AA, Bunney BS. The control of firing pattern in nigral dopamine neurons: burst firing. J Neurosci 1984;4:2877-2890 (Pubitemid 15224432)
28. Hajos M, Gartside SE, Villa AE, et al. Evidence for a repetitive (burst) firing pattern in a sub-population of 5-hydroxytryptamine neurons in the dorsal and median raphe nuclei of the rat. Neuroscience 1995;69:189-197
29. Kandel ER, Spencer WA. Electrophysiology of hippocampal neurons. II. After-potentials and repetitive firing. J Neurophysiol 1961;24:243-259
30. Ranck JB Jr. Studies on single neurons in dorsal hippocampal formation and septum in unrestrained rats. I. Behavioral correlates and firing repertoires. Exp Neurol 1973;41:461-531.
31. Florin-Lechner SM, Druhan JP, Aston-Jones G, et al. Enhanced norepinephrine release in prefrontal cortex with burst stimulation of the locus coeruleus. Brain Res 1996;742:89-97. (Pubitemid 27016011)
32. El Mansari M, Ghanbari R, Janssen S, et al. Sustained administration of bupropion alters the neuronal activity of serotonin, norepinephrine but not dopamine neurons in the rat brain. Neuropharmacology 2008;55:1191-1198
33. Ghanbari R, El Mansari M, Blier P. Electrophysiological effects of the co-administration of escitalopram and bupropion on rat serotonin and norepinephrine neurons. J Psychopharmacol 2008 Nov. 21 [Epub ahead of print].
34. Follesa P, Biggio F, Gorini G, et al. Vagus nerve stimulation increases norepinephrine concentration and the gene expression of BDNF and bFGF in the rat brain. Brain Res 2007; 1179:28-34. (Pubitemid 47633509)
35. Roosevelt RW, Smith DC, Clough RW, et al. Increased extracellular concentrations of norepinephrine in cortex and hippocampus following vagus nerve stimulation in the rat. Brain Res 2006;1119:124-132
36. Gobbi G, Cassano T, Radja F, et al. Neurokinin 1 receptor antagonism requires norepinephrine to increase serotonin function. Eur Neuropsychopharmacol 2007;17:328-338 (Pubitemid 46304207)
37. Henry TR. Therapeutic mechanisms of vagus nerve stimulation. Neurology 2002;59(Suppl 4):S3-14.
38. Van Bockstaele EJ, Peoples J, Telegan P. Efferent projections of the nucleus of the solitary tract to peri-locus coeruleus dendrites in rat brain: evidence for a monosynaptic pathway. J Comp Neurol 1999;412:410-428 (Pubitemid 29398700)
39. Ennis M, Aston-Jones G. Activation of locus coeruleus from nucleus paragigantocellularis: a new excitatory amino acid pathway in brain. J Neurosci 1988;8:3644-3657
40. Ennis M, Aston-Jones G. GABA-mediated inhibition of locus coeruleus from the dorsomedial rostral medulla. J Neurosci 1989;9:2973-2981 (Pubitemid 19214328)
41. Cunningham JT, Mifflin SW, Gould GG, et al. Induction of c-Fos and DeltaFosB immunoreactivity in rat brain by vagal nerve stimulation. Neuropsychopharmacology 2008;33:1884-1895
42. Bosker F, Klompmakers A, Westenberg H. Extracellular 5-hydroxytryptamine in median raphe nucleus of the conscious rat is decreased by nanomolar concentrations of 8-hydroxy-2-(di-n-propylamino) tetralin and is sensitive to tetrodotoxin. J Neurochem 1994;63:2165-2171 (Pubitemid 24984043)
43. Hery F, Faudon M, Fueri C. Release of serotonin in structures containing serotoninergic nerve cell bodies: dorsalis raphe nucleus and nodose ganglia of the cat. Ann N Y Acad Sci 1986;473:239-255
44. Baraban JM, Aghajanian GK. Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonists. Neuropharmacology 1980;19:355-363
45. Kasamo K, Suzuki T, Tada K, et al. Endogenous 5-HT tonically inhibits spontaneous firing activity of dorsal hippocampus CA1 pyramidal neurons through stimulation of 5-HT(1A) receptors in quiet awake rats: in vivo electrophysiological evidence. Neuropsychopharmacology 2001;24:141-151
46. Besson A, Haddjeri N, Blier P, et al. Effects of the co-administration of mirtazapine and paroxetine on serotonergic neurotransmission in the rat brain. Eur Neuropsychopharmacol 2000;10:177-188
47. Szabo ST, Blier P. Effects of the selective norepinephrine reuptake inhibitor reboxetine on norepinephrine and serotonin transmission in the rat hippocampus. Neuropsychopharmacology 2001;25:845-857 (Pubitemid 34031891)
48. Trulson ME, Jacobs BL. Raphe unit activity in freely moving cats: correlation with level of behavioral arousal. Brain Res 1979;163:135-150 (Pubitemid 9111292)
49. Haddjeri N, Blier P. Neurokinin-1 receptor antagonists modulate brain noradrenaline and serotonin interactions. Eur J Pharmacol 2008;600:64-70.